Healio (11/19, Gramigna) reports research appears to underscore “the significantly higher costs for privately insured adult patients diagnosed with major depressive disorder [MDD] and suicide ideation/attempt than adults without MDD.” Investigators arrived at this conclusion after examining data on “2,061 patients aged 18 to 64 years with MDD and suicide ideation/attempt using Optum Health Care Solutions database of privately insured patients.” The findings were presented at the annual meeting of the Academy of Managed Care Pharmacy – AMCP Nexus 2019.
Related Links:
— “Patients with MDD and suicide ideation/attempt experience significant health care costs, “Joe Gramigna, Healio, November 19, 2019